Transluminal coronary angioplasty, commonly referred to as percutaneous coronary intervention (PCI), stands as a pivotal medical procedure designed to address constricted or obstructed coronary arteries. These arteries play a crucial role in supplying blood to the heart muscle, and their blockage by plaque or fatty deposits can result in diminished blood flow, angina, or potential heart attacks. The procedure involves navigating a slender catheter, equipped with a balloon at its tip, through the blood vessels to the site of the blockage. Upon reaching the targeted location, the balloon is inflated, exerting pressure to compress the plaque and widen the artery, thereby restoring normal blood flow. In certain instances, the deployment of a stent—a minute mesh tube—serves to maintain the openness of the artery.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States